12/20
09:33 am
irwd
Here's Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD) [Yahoo! Finance]
High
Report
Here's Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD) [Yahoo! Finance]
11/26
04:01 pm
irwd
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/13
04:01 pm
irwd
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Medium
Report
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
11/12
02:01 am
irwd
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Medium
Report
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/8
04:10 am
irwd
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]
Medium
Report
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]
11/8
12:03 am
irwd
Ironwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
Medium
Report
Ironwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
11/7
07:00 am
irwd
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Medium
Report
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
11/6
07:41 am
irwd
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Medium
Report
Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/4
11:12 pm
irwd
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Medium
Report
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
10/28
07:00 am
irwd
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
Neutral
Report
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
10/24
04:00 pm
irwd
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
Low
Report
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call